Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

600329

Company Profile

  • Business description

    Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company is engaged in the production and sale of traditional Chinese medicine, Western medicine, healthcare products, and investment holding. It operates in two segments, namely the Chinese Medicine segment and the Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures Western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese medicine.

  • Contact

    No. 17 Baidi Road
    Darentang Building
    Nankai District
    Tianjin300193
    CHN

    T: +86 2227020598

    https://www.jydrt.com.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    3,890

Stocks News & Analysis

stocks

Nvidia: Hugging Face acquisition both a wise offensive and defensive move

We think this improves Nvidia’s position within the open-source community.
stocks

Anthropic’s IPO will be huge—and risky. Here are the challenges investors should watch

Part two of a Q&A with PitchBook senior analyst Harrison Rolfes about Anthropic, the AI giant’s challenges, and how much it’s worth.
stocks

Chart of the Week: China demand for copper falls amidst record rally

Elevated copper prices raise valuation questions.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,197.8052.80-0.57%
CAC 408,286.405.770.07%
DAX 4026,003.32163.990.63%
Dow JONES (US)53,686.11624.161.18%
FTSE 10010,831.5275.070.70%
HKSE25,734.82521.512.07%
NASDAQ26,584.06366.231.40%
Nikkei 22565,106.60892.121.39%
NZX 50 Index13,974.18128.000.92%
S&P 5007,747.7181.111.06%
S&P/ASX 2009,008.4061.80-0.68%
SSE Composite Index3,967.0524.960.63%

Market Movers